1Sugabara K, Yamada Y, Hirata Y, et al. Soluble and men brane isoform of Fas/CD95 in fresh adult T-cell leukemia (ALT) cells and ALT-cell lines[J]. Int J Cancer, 1997,72:126 - 132.
2Traver D, Akasbi K, WeissmaulL,et al. Mice defective in two apoptos ins pathwys in the myeloid liueage develop acute myeloblastic leukemia [ J Immunity, 1998,9:47 - 57.
3Munker R, Mid is G, Owen SL, et al. Soluable Fas (CD95) is not elevated in the serum of patients with myeloid leukemia in yeloproliferative and in yelodysplastic syudromes[ J ]. Leukemia, 1996,10:1531 - 1533.
4Sotomayor E M, DinapofiM R, Calderon C, et al. Decreased macrophagemediated cytotoxicity in mammary-tumol-bearing in ice is related to alteration of oitric-oxide preoduction and/or release[ J ]. int J Cancer, 1995,60(s) :660 - 667.
